Group 1 - The company held the 25th meeting of the 9th Board of Directors on August 14, 2025, where all 9 participating directors voted in favor of the proposals [2][4] - The meeting approved the proposal regarding the transfer of equity in a subsidiary, which will require further approval from the shareholders' meeting [3][5] - The company decided to postpone the shareholders' meeting based on work arrangements, with future notifications to be provided for the meeting [8][9] Group 2 - The Supervisory Board also held a meeting on August 14, 2025, where all 3 participating supervisors voted in favor of the same proposals [13][16] - The proposals from the Supervisory Board will also require approval from the shareholders' meeting [15][19] Group 3 - The company announced a guarantee extension that constitutes external guarantees, with a current guarantee balance of RMB 6.5 million for Guangxi Haiwang [22][32] - The company has a total guarantee balance of approximately RMB 49.76 billion, which is 174.96% of the audited net assets for 2024 [40][32] - The Supervisory Board believes that the guarantee extension will not harm the interests of the company and its shareholders [33] Group 4 - The company provided financial assistance due to a passive formation from the transfer of equity in a subsidiary, with an outstanding loan of RMB 2.7 million owed by Guangxi Haiwang [44][46] - The financial assistance will not affect the company's normal operations and is compliant with relevant regulations [46][54] - The company has provided a total of RMB 336.86 million in financial assistance, which is 11.85% of the audited net assets for 2024 [54][55]

广西海王作为广东海王集团子公司存续期间，广东海王集团为支持其日常经营向其提供往来资金，广西 海王尚欠广东海王集团借款本金270万元及利息，本次股权转让后被动形成公司对外提供财务资助，该 项业务实质为公司对原合并报表范围内子公司提供日常经营性资金的延续。截至目前，广西海王应向广 东海王集团归还的借款本金270万元及利息。 格隆汇8月14日丨海王生物(000078.SZ)公布，因市场情况发生变化，经公司与各方友好协商，公司控股 子公司广东海王集团与朱翰浩、广西海王的小股东龙睿(广州)生物科技有限公司签订了《股权转让协 议》，由朱翰浩收购广东海王集团持有的广西海王65%股权。股权转让完成后，广东海王集团不再持有 广西海王的股权，广西海王不再是公司合并范围内的子公司。 ...